Puma Biotechnology presents at B. Riley Oncology Conference; no material new information disclosed.

PUMA BIOTECHNOLOGY, INC.

Presentation at B. Riley Securities 4th Annual Oncology Conference on January 18, 2024.
Chairman, President and CEO Alan H. Auerbach to present.
Exhibit 99.1 presentation not included as extractable text; specifics unavailable.
No financial or operational updates disclosed in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.